Yana Dekempeneer

Person

Dekempeneer, Yana

Person

  1. 2020
  2. Therapeutic Efficacy of 213 Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer

    Dekempeneer, Y., Caveliers, V., Ooms, M., Gysemans, M., Lahoutte, T., Xavier, C., Lecocq, Q., Maes, K., Covens, P., Miller, B. W., Bruchertseifer, F., Morgenstern, A., Cardinaels, T. & D'huyvetter, M., 19 Jul 2020, In: Molecular Pharmaceutics. 17, 9, p. 3553-3566 14 p.

    Research output: Contribution to journalArticlepeer-review

  3. 2019
  4. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

    Dekempeneer, Y., Bäck, T., Aneheim, E., Jensen, H., Puttemans, J. & Xavier, C., 21 Jun 2019, In: Molecular Pharmaceutics. 16, 8, p. 3524-3533 10 p.

    Research output: Contribution to journalArticlepeer-review

ID: 1456213